APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transfusion Diagnosis for Donor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Transfusion Diagnosis for Donor Market Analysis and Forecast 2026-2032

15 January 2026190 pages

Choose your research edition.

Industry ResearchTransfusion Diagnosis for Donor Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Transfusion Diagnosis for Donor Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transfusion Diagnosis for Donor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transfusion Diagnosis for Donor Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Transfusion Diagnosis for Donor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Transfusion Diagnosis for Donor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Transfusion Diagnosis for Donor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Transfusion Diagnosis for Donor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Transfusion Diagnosis for Donor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Transfusion Diagnosis for Donor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Transfusion Diagnosis for Donor include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH and Diasorin, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Transfusion Diagnosis for Donor, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transfusion Diagnosis for Donor, also provides the revenue of main regions and countries. Of the upcoming market potential for Transfusion Diagnosis for Donor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transfusion Diagnosis for Donor revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transfusion Diagnosis for Donor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Transfusion Diagnosis for Donor revenue, projected growth trends, production technology, application and end-user industry.

Transfusion Diagnosis for Donor Segment by Company

Grifols

F. Hoffmann-La Roche

Abbott

Bio-Rad Laboratories

Werfen

QuidelOrtho Corporation

AliveDx Holdings Finance

BAG Diagnostics GmbH

Diasorin

Prestige Diagnostics

Atlas Medical GmbH

Lorne Laboratories

Transfusion Diagnosis for Donor Segment by Type

Instruments

Kits and Reagents

Transfusion Diagnosis for Donor Segment by Application

Blood Banks

Blood Donation/Transfusion Centers

Others

Transfusion Diagnosis for Donor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transfusion Diagnosis for Donor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transfusion Diagnosis for Donor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transfusion Diagnosis for Donor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transfusion Diagnosis for Donor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transfusion Diagnosis for Donor company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transfusion Diagnosis for Donor revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Instruments Major Player Table 3. Kits and Reagents Major Player Table 4. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Blood Banks Major Player Table 6. Blood Donation/Transfusion Centers Major Player Table 7. Others Major Player Table 8. Transfusion Diagnosis for Donor Industry Trends Table 9. Transfusion Diagnosis for Donor Industry Drivers Table 10. Transfusion Diagnosis for Donor Industry Opportunities and Challenges Table 11. Transfusion Diagnosis for Donor Industry Restraints Table 12. Global Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Transfusion Diagnosis for Donor Market Share by Region (2021-2026) Table 15. Global Transfusion Diagnosis for Donor Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Transfusion Diagnosis for Donor Market Share by Region (2027-2032) Table 17. Global Transfusion Diagnosis for Donor Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Transfusion Diagnosis for Donor Revenue Market Share by Players (2021-2026) Table 19. Global Transfusion Diagnosis for Donor Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Transfusion Diagnosis for Donor Key Players Headquarters & Area Served Table 21. Global Transfusion Diagnosis for Donor Players, Product Type & Application Table 22. Global Transfusion Diagnosis for Donor Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Transfusion Diagnosis for Donor by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Transfusion Diagnosis for Donor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Transfusion Diagnosis for Donor Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Transfusion Diagnosis for Donor Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2021-2026) Table 29. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2027-2032) Table 30. Global Transfusion Diagnosis for Donor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Transfusion Diagnosis for Donor Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Transfusion Diagnosis for Donor Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021-2026) Table 34. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2027-2032) Table 35. Grifols Company Information Table 36. Grifols Business Overview Table 37. Grifols Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Grifols Transfusion Diagnosis for Donor Product Portfolio Table 39. Grifols Recent Development Table 40. F. Hoffmann-La Roche Company Information Table 41. F. Hoffmann-La Roche Business Overview Table 42. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio Table 44. F. Hoffmann-La Roche Recent Development Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Abbott Transfusion Diagnosis for Donor Product Portfolio Table 49. Abbott Recent Development Table 50. Bio-Rad Laboratories Company Information Table 51. Bio-Rad Laboratories Business Overview Table 52. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio Table 54. Bio-Rad Laboratories Recent Development Table 55. Werfen Company Information Table 56. Werfen Business Overview Table 57. Werfen Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Werfen Transfusion Diagnosis for Donor Product Portfolio Table 59. Werfen Recent Development Table 60. QuidelOrtho Corporation Company Information Table 61. QuidelOrtho Corporation Business Overview Table 62. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio Table 64. QuidelOrtho Corporation Recent Development Table 65. AliveDx Holdings Finance Company Information Table 66. AliveDx Holdings Finance Business Overview Table 67. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio Table 69. AliveDx Holdings Finance Recent Development Table 70. BAG Diagnostics GmbH Company Information Table 71. BAG Diagnostics GmbH Business Overview Table 72. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio Table 74. BAG Diagnostics GmbH Recent Development Table 75. Diasorin Company Information Table 76. Diasorin Business Overview Table 77. Diasorin Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Diasorin Transfusion Diagnosis for Donor Product Portfolio Table 79. Diasorin Recent Development Table 80. Prestige Diagnostics Company Information Table 81. Prestige Diagnostics Business Overview Table 82. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio Table 84. Prestige Diagnostics Recent Development Table 85. Atlas Medical GmbH Company Information Table 86. Atlas Medical GmbH Business Overview Table 87. Atlas Medical GmbH Transfusion Diagnosis for Donor Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio Table 89. Atlas Medical GmbH Recent Development Table 90. Lorne Laboratories Company Information Table 91. Lorne Laboratories Business Overview Table 92. Lorne Laboratories Transfusion Diagnosis for Donor Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio Table 94. Lorne Laboratories Recent Development Table 95. North America Transfusion Diagnosis for Donor Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Transfusion Diagnosis for Donor Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Transfusion Diagnosis for Donor Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Transfusion Diagnosis for Donor Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Transfusion Diagnosis for Donor Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Transfusion Diagnosis for Donor Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Transfusion Diagnosis for Donor Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Transfusion Diagnosis for Donor Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Transfusion Diagnosis for Donor Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Transfusion Diagnosis for Donor Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Transfusion Diagnosis for Donor Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Transfusion Diagnosis for Donor Revenue by Country (US$ Million) & (2027-2032) Table 109. China Transfusion Diagnosis for Donor Revenue by Type (2021-2026) & (US$ Million) Table 110. China Transfusion Diagnosis for Donor Revenue by Type (2027-2032) & (US$ Million) Table 111. China Transfusion Diagnosis for Donor Revenue by Application (2021-2026) & (US$ Million) Table 112. China Transfusion Diagnosis for Donor Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Transfusion Diagnosis for Donor Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Transfusion Diagnosis for Donor Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Transfusion Diagnosis for Donor Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Transfusion Diagnosis for Donor Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Transfusion Diagnosis for Donor Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Transfusion Diagnosis for Donor Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Transfusion Diagnosis for Donor Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Transfusion Diagnosis for Donor Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Transfusion Diagnosis for Donor Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Transfusion Diagnosis for Donor Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Transfusion Diagnosis for Donor Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Transfusion Diagnosis for Donor Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Transfusion Diagnosis for Donor Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Transfusion Diagnosis for Donor Image Figure 2. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transfusion Diagnosis for Donor Market Size Share 2021 VS 2025 VS 2032 Figure 4. Instruments Image Figure 5. Kits and Reagents Image Figure 6. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Transfusion Diagnosis for Donor Market Size Share 2021 VS 2025 VS 2032 Figure 8. Blood Banks Image Figure 9. Blood Donation/Transfusion Centers Image Figure 10. Others Image Figure 11. Global Transfusion Diagnosis for Donor Market Size (US$ Million) & (2021-2032) Figure 12. Global Transfusion Diagnosis for Donor Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Transfusion Diagnosis for Donor Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Transfusion Diagnosis for Donor Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Transfusion Diagnosis for Donor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Transfusion Diagnosis for Donor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2021-2032) Figure 19. Global Transfusion Diagnosis for Donor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021-2032) Figure 22. North America Transfusion Diagnosis for Donor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032) Figure 24. North America Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032) Figure 25. North America Transfusion Diagnosis for Donor Revenue Share by Country (2021-2032) Figure 26. United States Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Transfusion Diagnosis for Donor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032) Figure 31. Europe Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032) Figure 32. Europe Transfusion Diagnosis for Donor Revenue Share by Country (2021-2032) Figure 33. Germany Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Transfusion Diagnosis for Donor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032) Figure 43. China Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032) Figure 44. Asia Transfusion Diagnosis for Donor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032) Figure 46. Asia Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032) Figure 47. Asia Transfusion Diagnosis for Donor Revenue Share by Region (2021-2032) Figure 48. Japan Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Transfusion Diagnosis for Donor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032) Figure 56. SAMEA Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032) Figure 57. SAMEA Transfusion Diagnosis for Donor Revenue Share by Country (2021-2032) Figure 58. Brazil Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Transfusion Diagnosis for Donor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Kits and Reagents
Applications
  • Blood Banks
  • Blood Donation/Transfusion Centers
  • Others
Companies covered
  • Grifols
  • F. Hoffmann-La Roche
  • Abbott
  • Bio-Rad Laboratories
  • Werfen
  • QuidelOrtho Corporation
  • AliveDx Holdings Finance
  • BAG Diagnostics GmbH
  • Diasorin
  • Prestige Diagnostics
  • Atlas Medical GmbH
  • Lorne Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transfusion Diagnosis for Donor Market by Type
  3. 1.2.1 Global Transfusion Diagnosis for Donor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Instruments
  5. 1.2.3 Kits and Reagents
  6. 1.3 Transfusion Diagnosis for Donor Market by Application
  7. 1.3.1 Global Transfusion Diagnosis for Donor Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Blood Banks
  9. 1.3.3 Blood Donation/Transfusion Centers
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Transfusion Diagnosis for Donor Market Dynamics
  1. 2.1 Transfusion Diagnosis for Donor Industry Trends
  2. 2.2 Transfusion Diagnosis for Donor Industry Drivers
  3. 2.3 Transfusion Diagnosis for Donor Industry Opportunities and Challenges
  4. 2.4 Transfusion Diagnosis for Donor Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Transfusion Diagnosis for Donor Market Perspective (2021-2032)
  2. 3.2 Global Transfusion Diagnosis for Donor Growth Trends by Region
  3. 3.2.1 Global Transfusion Diagnosis for Donor Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
  5. 3.2.3 Global Transfusion Diagnosis for Donor Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Transfusion Diagnosis for Donor Revenue by Players
  2. 4.1.1 Global Transfusion Diagnosis for Donor Revenue by Players (2021-2026)
  3. 4.1.2 Global Transfusion Diagnosis for Donor Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Transfusion Diagnosis for Donor Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transfusion Diagnosis for Donor Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Transfusion Diagnosis for Donor Key Players Headquarters & Area Served
  7. 4.4 Global Transfusion Diagnosis for Donor Players, Product Type & Application
  8. 4.5 Global Transfusion Diagnosis for Donor Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Transfusion Diagnosis for Donor Market CR5 and HHI
  11. 4.6.3 2025 Transfusion Diagnosis for Donor Tier 1, Tier 2, and Tier 3
5 Transfusion Diagnosis for Donor Market Size by Type
  1. 5.1 Global Transfusion Diagnosis for Donor Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Transfusion Diagnosis for Donor Revenue by Type (2021-2032)
  3. 5.3 Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2021-2032)
6 Transfusion Diagnosis for Donor Market Size by Application
  1. 6.1 Global Transfusion Diagnosis for Donor Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Transfusion Diagnosis for Donor Revenue by Application (2021-2032)
  3. 6.3 Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Grifols
  2. 7.1.1 Grifols Company Information
  3. 7.1.2 Grifols Business Overview
  4. 7.1.3 Grifols Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Grifols Transfusion Diagnosis for Donor Product Portfolio
  6. 7.1.5 Grifols Recent Developments
  7. 7.2 F. Hoffmann-La Roche
  8. 7.2.1 F. Hoffmann-La Roche Company Information
  9. 7.2.2 F. Hoffmann-La Roche Business Overview
  10. 7.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  11. 7.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio
  12. 7.2.5 F. Hoffmann-La Roche Recent Developments
  13. 7.3 Abbott
  14. 7.3.1 Abbott Company Information
  15. 7.3.2 Abbott Business Overview
  16. 7.3.3 Abbott Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Abbott Transfusion Diagnosis for Donor Product Portfolio
  18. 7.3.5 Abbott Recent Developments
  19. 7.4 Bio-Rad Laboratories
  20. 7.4.1 Bio-Rad Laboratories Company Information
  21. 7.4.2 Bio-Rad Laboratories Business Overview
  22. 7.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio
  24. 7.4.5 Bio-Rad Laboratories Recent Developments
  25. 7.5 Werfen
  26. 7.5.1 Werfen Company Information
  27. 7.5.2 Werfen Business Overview
  28. 7.5.3 Werfen Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Werfen Transfusion Diagnosis for Donor Product Portfolio
  30. 7.5.5 Werfen Recent Developments
  31. 7.6 QuidelOrtho Corporation
  32. 7.6.1 QuidelOrtho Corporation Company Information
  33. 7.6.2 QuidelOrtho Corporation Business Overview
  34. 7.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  35. 7.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio
  36. 7.6.5 QuidelOrtho Corporation Recent Developments
  37. 7.7 AliveDx Holdings Finance
  38. 7.7.1 AliveDx Holdings Finance Company Information
  39. 7.7.2 AliveDx Holdings Finance Business Overview
  40. 7.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio
  42. 7.7.5 AliveDx Holdings Finance Recent Developments
  43. 7.8 BAG Diagnostics GmbH
  44. 7.8.1 BAG Diagnostics GmbH Company Information
  45. 7.8.2 BAG Diagnostics GmbH Business Overview
  46. 7.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio
  48. 7.8.5 BAG Diagnostics GmbH Recent Developments
  49. 7.9 Diasorin
  50. 7.9.1 Diasorin Company Information
  51. 7.9.2 Diasorin Business Overview
  52. 7.9.3 Diasorin Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Diasorin Transfusion Diagnosis for Donor Product Portfolio
  54. 7.9.5 Diasorin Recent Developments
  55. 7.10 Prestige Diagnostics
  56. 7.10.1 Prestige Diagnostics Company Information
  57. 7.10.2 Prestige Diagnostics Business Overview
  58. 7.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio
  60. 7.10.5 Prestige Diagnostics Recent Developments
  61. 7.11 Atlas Medical GmbH
  62. 7.11.1 Atlas Medical GmbH Company Information
  63. 7.11.2 Atlas Medical GmbH Business Overview
  64. 7.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio
  66. 7.11.5 Atlas Medical GmbH Recent Developments
  67. 7.12 Lorne Laboratories
  68. 7.12.1 Lorne Laboratories Company Information
  69. 7.12.2 Lorne Laboratories Business Overview
  70. 7.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio
  72. 7.12.5 Lorne Laboratories Recent Developments
8 North America
  1. 8.1 North America Transfusion Diagnosis for Donor Revenue (2021-2032)
  2. 8.2 North America Transfusion Diagnosis for Donor Revenue by Type (2021-2032)
  3. 8.2.1 North America Transfusion Diagnosis for Donor Revenue by Type (2021-2026)
  4. 8.2.2 North America Transfusion Diagnosis for Donor Revenue by Type (2027-2032)
  5. 8.3 North America Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032)
  6. 8.4 North America Transfusion Diagnosis for Donor Revenue by Application (2021-2032)
  7. 8.4.1 North America Transfusion Diagnosis for Donor Revenue by Application (2021-2026)
  8. 8.4.2 North America Transfusion Diagnosis for Donor Revenue by Application (2027-2032)
  9. 8.5 North America Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032)
  10. 8.6 North America Transfusion Diagnosis for Donor Revenue by Country
  11. 8.6.1 North America Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Transfusion Diagnosis for Donor Revenue by Country (2021-2026)
  13. 8.6.3 North America Transfusion Diagnosis for Donor Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Transfusion Diagnosis for Donor Revenue (2021-2032)
  2. 9.2 Europe Transfusion Diagnosis for Donor Revenue by Type (2021-2032)
  3. 9.2.1 Europe Transfusion Diagnosis for Donor Revenue by Type (2021-2026)
  4. 9.2.2 Europe Transfusion Diagnosis for Donor Revenue by Type (2027-2032)
  5. 9.3 Europe Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032)
  6. 9.4 Europe Transfusion Diagnosis for Donor Revenue by Application (2021-2032)
  7. 9.4.1 Europe Transfusion Diagnosis for Donor Revenue by Application (2021-2026)
  8. 9.4.2 Europe Transfusion Diagnosis for Donor Revenue by Application (2027-2032)
  9. 9.5 Europe Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032)
  10. 9.6 Europe Transfusion Diagnosis for Donor Revenue by Country
  11. 9.6.1 Europe Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Transfusion Diagnosis for Donor Revenue by Country (2021-2026)
  13. 9.6.3 Europe Transfusion Diagnosis for Donor Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Transfusion Diagnosis for Donor Revenue (2021-2032)
  2. 10.2 China Transfusion Diagnosis for Donor Revenue by Type (2021-2032)
  3. 10.2.1 China Transfusion Diagnosis for Donor Revenue by Type (2021-2026)
  4. 10.2.2 China Transfusion Diagnosis for Donor Revenue by Type (2027-2032)
  5. 10.3 China Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032)
  6. 10.4 China Transfusion Diagnosis for Donor Revenue by Application (2021-2032)
  7. 10.4.1 China Transfusion Diagnosis for Donor Revenue by Application (2021-2026)
  8. 10.4.2 China Transfusion Diagnosis for Donor Revenue by Application (2027-2032)
  9. 10.5 China Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transfusion Diagnosis for Donor Revenue (2021-2032)
  2. 11.2 Asia Transfusion Diagnosis for Donor Revenue by Type (2021-2032)
  3. 11.2.1 Asia Transfusion Diagnosis for Donor Revenue by Type (2021-2026)
  4. 11.2.2 Asia Transfusion Diagnosis for Donor Revenue by Type (2027-2032)
  5. 11.3 Asia Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032)
  6. 11.4 Asia Transfusion Diagnosis for Donor Revenue by Application (2021-2032)
  7. 11.4.1 Asia Transfusion Diagnosis for Donor Revenue by Application (2021-2026)
  8. 11.4.2 Asia Transfusion Diagnosis for Donor Revenue by Application (2027-2032)
  9. 11.5 Asia Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032)
  10. 11.6 Asia Transfusion Diagnosis for Donor Revenue by Country
  11. 11.6.1 Asia Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Transfusion Diagnosis for Donor Revenue by Country (2021-2026)
  13. 11.6.3 Asia Transfusion Diagnosis for Donor Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transfusion Diagnosis for Donor Revenue (2021-2032)
  2. 12.2 SAMEA Transfusion Diagnosis for Donor Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Transfusion Diagnosis for Donor Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Transfusion Diagnosis for Donor Revenue by Type (2027-2032)
  5. 12.3 SAMEA Transfusion Diagnosis for Donor Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Transfusion Diagnosis for Donor Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Transfusion Diagnosis for Donor Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Transfusion Diagnosis for Donor Revenue by Application (2027-2032)
  9. 12.5 SAMEA Transfusion Diagnosis for Donor Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Transfusion Diagnosis for Donor Revenue by Country
  11. 12.6.1 SAMEA Transfusion Diagnosis for Donor Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Transfusion Diagnosis for Donor Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Transfusion Diagnosis for Donor Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst